Caspase-3 gene transfected with LIGHT gene:: can it be used for therapy of human hepatocellular carcinoma?
Caspase-3 gene transfected with LIGHT gene:: can it be used for therapy of human hepatocellular carcinoma?
复制标题
DOI:
10.1515/cclm.2008.094
复制
发表时间:
2008-01-01
影响因子:
6.8
通讯作者:
Han, Bing
中科院分区:
文献类型:
--
作者:
Lu, Yun;Wu, Li-Qun;Han, Bing
Background: The aim of this study was to detect the expression of apoptosis factor caspase-3 in transferred HepG(2) cells and provide feasible evaluation of the treatment for primary liver cancer with gene methods.Methods: The pcDNA4C-LIGHT cDNA was extracted from Escherichia coli JM-109; then, the pcDNA4C-LIGHT cDNA was transferred into the HepG2 cells by a cationic liposome mediated method. Meanwhile, the blank group was established as the control group and the HepG(2) cells were collected after transfection at 12 h, 24 h, 48 h, 3 days and 5 days. The expression of caspase-3 was identified in the supernatants by ELISA. A standard curve was generated for the set of samples assayed. Statistical significance was analyzed by SPSS.Results: The quantity of caspase-3 protein was the greatest at 48 h and the least on day 5. The secretion of caspase-3 did not increase in the control group. The coefficient of correlation was equal to 0.9986 and had evident significance.Conclusions: The pcDNA4C-LIGHT was effectively transfected in human HepG(2) cells mediated by liposome. The expression of caspase-3 increased in the transfected group. This study provides necessary theoretic support for the treatment of liver cancer with gene methods.